DoD Peer Reviewed Medical Research Program Technology/Therapeutic Development Award

Opportunity ID: 45051

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-09-PRMRP-TTDA
Funding Opportunity Title: DoD Peer Reviewed Medical Research Program Technology/Therapeutic Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation: CategoryExplanation
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 29, 2009
Last Updated Date:
Original Closing Date for Applications: Apr 16, 2009
Current Closing Date for Applications: Apr 16, 2009
Archive Date: May 16, 2009
Estimated Total Program Funding: $5,800,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: This award is intended to support for the translation of promising preclinical findings into products for clinical applications in at least one of the congressionally-directed FY09 PRMRP topic areas. These products should be responsive to the health care needs of the Armed Forces, their family members, and/or the U.S. Veteran population. All applications must specifically and clearly address the military relevance of the proposed research. Collaboration with military researchers and clinicians is encouraged.
The product(s) to be developed may be pharmacologic agents (drugs or biologicals), devices, or clinical guidance. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award. Examples of the types of research that may be supported include, but are not limited to:
• Collection and analysis of data for developing and validating clinical guidance
• Testing new therapeutic modalities (agents, delivery systems, chemical modification of lead compounds) using established or validated novel preclinical systems
• Designing and implementing full-scale, pilot Good Manufacturing Practice (GMP) production of therapeutics and/or delivery systems for use in advanced preclinical and initial clinical trials
• Developing pharmacologic agents through adsorption, distribution, metabolism, excretion, and toxicity (ADMET) phase
• Developing pharmacologic agents to Investigational New Drug (IND) stage for initiation of Phase I clinical trials
• Developing prototype devices for diagnosis or treatment to Investigational Device Exemption (IDE) stage for initiation of Phase I clinical trials
• Optimizing diagnostic or treatment devices for field deployment
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil

eReceipt HELP: 301-682-5507; help@cdmrp.org

Email:cdmrp.pa@amedd.army.mil

Version History

Version Modification Description Updated Date

Folder 45051 Full Announcement-1 -> biosketch.pdf

Folder 45051 Full Announcement-1 -> TTDA PA.pdf

Folder 45051 Full Announcement-1 -> Budget Form Reader.pdf

Packages

Agency Contact Information: PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org

Email: cdmrp.pa@amedd.army.mil

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00010239 Jan 29, 2009 Apr 16, 2009 View

Package 1

Mandatory forms

45051 RR_SF424-1.1.pdf

45051 RR_PerformanceSite-1.1.pdf

45051 RR_KeyPersonExpanded-1.1.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *